미네소타의 다발성 골수종 임상 시험
다발성 골수종 관련 연구 31개가 미네소타 내 여러 지역에서 참여자를 모집하고 있습니다.
미네소타의 도시
공식 연구 텍스트(영어)
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Mayo Clinic - Rochester /ID# 251164, Rochester
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT05650632A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
- Mayo Clinic, Rochester
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT05137054A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
- Mayo Clinic, Rochester
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07393282A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
- Mayo Clinic Rochester, Rochester
피험자 모집 중4상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT05201781A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
- Mayo Clinic Rochester, Rochester
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07258511Family Study of Lymphoproliferative Disorders
- Mayo Clinic, Rochester
피험자 모집 중관찰 연구건강한 지원자 환영
18세 ~ 100세 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT00626496A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
- Mayo Clinic - Minnesota, Rochester
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT07284758Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
- Mayo Clinic in Rochester, Rochester
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT06465316A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
- Mayo Clinic - Transplant Center - Rochester, Rochester
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT05651932A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
- Research Site, Rochester
피험자 모집 중3상
18세 ~ 130세 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT07735637Wisconsin Ginseng for Decreasing Cancer Related Fatigue
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Sanford Joe Lueken Cancer Center, Bemidji
- Essentia Health Saint Joseph's Medical Center, Brainerd
- 외 11개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT06395441A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
- Minnesota Oncology - Minneapolis Clinic /ID# 278720, Minneapolis
- Mayo Clinic Hospital Rochester /ID# 277886, Rochester
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07095452AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
- Research Site, Minneapolis
- Research Site, Rochester
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT05850234Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Mayo Clinic in Rochester, Minnesota, Rochester
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT06297226Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Mayo Clinic Health System-Mankato, Mankato
- Mayo Clinic in Rochester, Rochester
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06630104SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
- Mayo Clinic in Rochester, Rochester
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07850284A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- University Of Minnesota Medical Center, Minneapolis
- Mayo Clinic, Rochester
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07518186Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
- Mayo Clinic Rochester, Rochester
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT06375044Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
- Mayo Clinic in Rochester, Rochester
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT06940297Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- Minnesota Oncology - Burnsville, Burnsville
- Cambridge Medical Center, Cambridge
- Minnesota Oncology Hematology PA-Chaska, Chaska
- 외 24개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT04566328A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
- Mayo Clinic in Rochester, Minnesota, Rochester
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 16. 업데이트됨 · NCT06121843Integrated Cancer Repository for Cancer Research
- Riverwood Healthcare Center, Aitkin
- Essentia Health-St. Joseph's Medical Center, Brainerd
- Essentia Health - Duluth Clinic, Duluth
- 외 2개
피험자 모집 중관찰 연구건강한 지원자 환영
19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma
- Mayo Clinic in Rochester, Rochester
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 25. 업데이트됨 · NCT06785415Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
- Masonic Cancer Center at University of Minnesota, Minneapolis
피험자 모집 중2상
60세 이하 · 모든 성별 · 2026. 6. 25. 업데이트됨 · NCT03314974Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Sanford Joe Lueken Cancer Center, Bemidji
- 외 40개
피험자 모집 중3상
전 연령 · 모든 성별 · 2026. 6. 10. 업데이트됨 · NCT05561387A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- Mayo Clinic in Rochester, Rochester
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 10. 업데이트됨 · NCT03017820Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
- University of Minnesota - Masonic Cancer Center, Minneapolis
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 6. 5. 업데이트됨 · NCT03858205Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
- Minnesota Oncology Hematology, Minneapolis
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 4. 22. 업데이트됨 · NCT05972135Remote Monitoring With Health-Coaching to Improve Quality of Life in Older Patients With Multiple Myeloma
- Mayo Clinic in Rochester, Rochester
피험자 모집 중
65세 이상 · 모든 성별 · 2026. 4. 13. 업데이트됨 · NCT06145581IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
- University of Minnesota, Minneapolis
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 6. 3. 업데이트됨 · NCT06119685Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
- Center for International Blood and Marrow Transplant Research, Minneapolis
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2023. 8. 30. 업데이트됨 · NCT03127761ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.